The case reports of AEs of cinacalcet at the SOC level in FAERS.

<p>Distribution of reported adverse events across organ systems, showing the number of events for each SOC category.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Junxia Cao (460266) (author)
مؤلفون آخرون:	Na Yang (266025) (author), Cheng Huang (115619) (author)
منشور في:	2025
الموضوعات:	Medicine Genetics Pharmacology Biotechnology Developmental Biology Cancer Science Policy Infectious Diseases Virology system organ classes prevent serious complications including precocious puberty higher reporting frequency 74 age group primary suspect drug drug &# 8217 60 &# 8211 including known aes adverse events based 540 ae reports adverse events drug administration &# 8805 ae reports 60 days adverse reactions xlink "> study utilized socs ), signal mining safety evaluation risk signals renal insufficiency related aes prompt interventions prescribing information preferred terms parathyroid hemorrhage pancreatic atrophy highest proportion heart failure first quarter females exhibited epigastric pain disease progression conducted prior close monitoring clinical use cardiac death assess signals abdominal discomfort 85 %). 80 %). 7 days 35 %) 14 %)
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة